𝔖 Bobbio Scriptorium
✦   LIBER   ✦

253 Clinical development of histone deacetylase inhibitors

✍ Scribed by V. Richon

Book ID
118621436
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
141 KB
Volume
2
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Strategies in developing promising histo
Strategies in developing promising histone deacetylase inhibitors
✍ Lei Zhang; Hao Fang; Wenfang Xu πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 355 KB

## Abstract Histone deacetylases (HDACs) are a family of enzymes that have been of interest in drug discovery for more than 30 years. Inhibitors of HDACs are potential therapeutics for various diseases, such as neurodegenerative diseases, inflammation, viral infection, and especially cancer. Most H

Rational Design and Development of Radia
Rational Design and Development of Radiation-Sensitizing Histone Deacetylase Inhibitors
✍ Mira Jung; Alan Kozikowski; Anatoly Dritschilo πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 102 KB πŸ‘ 2 views

Histone deacetylases (HDACs) offer potentially attractive molecular targets for sensitizing cancers to treatment with radiation therapy. By affecting patterns of gene expression, differentiation, apoptosis, and enhanced responses to therapeutic agents may be induced in cancer cells. Here, we review